Anthocyanins Inhibit Nuclear Factor-B 31/05/2010
Multiple effects of anthocyanins inhibiting influenza (flu) virus infectivity 31/05/2010
Cardiovascular study on Medox and cholesterol and CETP 31/05/2010
Medox® is an absolute unique, patented, clinical well documented, professional food supplement. The development of Medox® was based on 16 years of research at a Norwegian university. The clinical research on Medox® has taken place, and are talking place, in university hospitals and in universities in Norway, EU, Asia and USA.
Medox® is not based on a standard berry extract. It is based on a high technological, patented process, developed by the Biolink Group. The whole process of Medox® is constructed to optimize on the few ortodihydroxy structured anthocyanins. These molecules are believed to carry the absolute highest biological potential among all anthocyanins.
The molecules in Medox® are found in bilberries and in blackcurrant. Both berry species are needed to give the unique biological structure and effect of Medox®.
Medox® is manly marketed through therapists and other health educated persons, and through pharmacies. The product is recommended by increasingly more doctors. Medox® is so far approved to be marketed in Norway, Sweden and USA(FDA). Medox® is recommended by the hearth and lung associations in both Norway and Sweden. It has been on the market since 2001, without documenting any possible side effects.